Year of establishment
2007
Location
Beograd
Founder
Lovorka Nikolić, Miomir Nikolić
Business information
2018
2021
2023
Full-time employees
176
192
191
Turnover (EUR)
9,8 mil
11,4 mil
18,4 mil
Export (EUR)
2,6 mil
4,2 mil
5,8 mil
Products/Services:
Esensa’s portfolio includes over 200 products in the categories of dietary supplements, medical devices, biocides, and cosmetics, covering almost all therapeutic areas. Some of the most well-known products are: Marisol nasal spray, the Propomint collection based on propolis, EsenBak probiotics, and Xibiz repellents.
Highlight a business move you made in 2023 that you are particularly proud of:
In 2023, we achieved significant revenue growth, reaching 23%, with a 35% increase in the domestic market and a 23% growth in exports. Our intensive market investments delivered the expected results, as evidenced by a 38% increase in EBITDA.
Export to over 40 markets worldwide, including countries such as: Czech Republic, China, Azerbaijan, Vietnam, Kuwait, and Poland
Rank the suggested initiatives as your contribution to the New Growth Agenda for the SME sector based on their importance to your business.
(Please rank the provided responses from 1 to 6, where 1 is the most important to you and 6 is the least important – priorities must not be repeated):
Establishment of a Development Bank: A bank where you could borrow under more favorable conditions.
1
Tax Credit: The possibility of not paying profit tax on the part of the profit that you reinvest.
2
Equal Opportunity for All: A business environment that is guaranteed to be predictable and free from corruption.
3
Independent Development Agency for SMEs: An agency that you could contact to develop support measures tailored to your needs and the needs of the Serbian economy.
5
Providing Opportunities for Domestic SMEs to Participate in Expo 2027 Projects: Promoting the integration of domestic SMEs into international events such as Expo 2027, increasing their visibility and market opportunities.
4
Strengthening Support Programs: Improving existing support programs with better targeting and providing technical assistance to ensure SMEs can fully utilize available resources.
6
If your company had the opportunity to participate in Expo 2027 (either in the preparation of Expo 2027 or at the Expo 2027 event itself), how do you think you could participate?
As a domestic pharmaceutical manufacturer, we have the opportunity to present our products, hold B2B meetings with potential international partners, create products that could be sold or gifted to tourists (e.g., a traditional balm based on propolis as a “gift from Serbia”), and showcase our products at EXPO.
What improvements and programs would you suggest that you think could contribute to your business and the Serbian economy?
More favorable loans for investments in production facilities and IT infrastructure (digitalization) to remain competitive with multinational companies, at least equal status and conditions with foreign investors, reduced bureaucracy, and increased presence at international trade fairs.
